Attendees: Richard Manuel, Tom Payne, Gavin Allsop
Comprehensive programme focused on the latest gene editing technical developments and therapy applications.
As part of the SynGen Series UK, the 5th Annual Gene Editing Congress gathers over 600 senior-level delegates and over 20 case studies and presentations discussing novel genome editing technologies and their therapeutic applications. The extensive schedule brings together the key work in academia and pharma in the gene editing field to improve techniques facilitating disease modelling, drug development and clinical studies. Taking place at the Novotel London West Hotel venue in London, it includes a featured workshop on ‘The Advancement of CRISPR In Discovery and Therapeutic Development’.